130 related articles for article (PubMed ID: 15200121)
21. Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damage.
Ito M; Ohba S; Gaensler K; Ronen SM; Mukherjee J; Pieper RO
PLoS One; 2013; 8(5):e62351. PubMed ID: 23667469
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.
Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM
J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis.
Jin ZH; Kurosu T; Yamaguchi M; Arai A; Miura O
Oncogene; 2005 Mar; 24(12):1973-81. PubMed ID: 15674326
[TBL] [Abstract][Full Text] [Related]
24. [Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways].
Yuan JP; Ling H; Zhang MX; Liu Y; Song Y; Su Q
Ai Zheng; 2004 Feb; 23(2):169-72. PubMed ID: 14960237
[TBL] [Abstract][Full Text] [Related]
25. The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer.
Yin M; Hapke G; Guo B; Azrak RG; Frank C; Rustum YM
Oncogene; 2001 Aug; 20(38):5249-57. PubMed ID: 11536038
[TBL] [Abstract][Full Text] [Related]
26. p53-dependent Chk1 phosphorylation is required for maintenance of prolonged G2 Arrest.
Wang XQ; Stanbridge EJ; Lao X; Cai Q; Fan ST; Redpath JL
Radiat Res; 2007 Dec; 168(6):706-15. PubMed ID: 18088187
[TBL] [Abstract][Full Text] [Related]
27. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
Momota H; Nerio E; Holland EC
Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
Liu X; Guo Y; Li Y; Jiang Y; Chubb S; Azuma A; Huang P; Matsuda A; Hittelman W; Plunkett W
Cancer Res; 2005 Aug; 65(15):6874-81. PubMed ID: 16061671
[TBL] [Abstract][Full Text] [Related]
29. Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways.
Yuan JP; Wang GH; Ling H; Su Q; Yang YH; Song Y; Tang RJ; Liu Y; Huang C
World J Gastroenterol; 2004 Sep; 10(18):2731-4. PubMed ID: 15309729
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
31. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest.
Chen Y; Miao ZH; Zhao WM; Ding J
FEBS Lett; 2005 Jul; 579(17):3683-90. PubMed ID: 15963507
[TBL] [Abstract][Full Text] [Related]
32. Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis.
Ueno H; Tomiyama A; Yamaguchi H; Uekita T; Shirakihara T; Nakashima K; Otani N; Wada K; Sakai R; Arai H; Mori K
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):240-7. PubMed ID: 26518652
[TBL] [Abstract][Full Text] [Related]
33. Multifaceted resistance of gliomas to temozolomide.
Bocangel DB; Finkelstein S; Schold SC; Bhakat KK; Mitra S; Kokkinakis DM
Clin Cancer Res; 2002 Aug; 8(8):2725-34. PubMed ID: 12171906
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
Hapke G; Yin MB; Wu J; Frank C; Rustum YM
Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway.
Liu X; Wang L; Chen J; Ling Q; Wang H; Li S; Li L; Yang S; Xia M; Jing L
Mol Med Rep; 2015 Feb; 11(2):1516-22. PubMed ID: 25351348
[TBL] [Abstract][Full Text] [Related]
36. MutL homolog 1 contributes to temozolomide-induced autophagy via ataxia-telangiectasia mutated in glioma.
Zou Y; Wang Q; Wang W
Mol Med Rep; 2015 Jun; 11(6):4591-6. PubMed ID: 25646660
[TBL] [Abstract][Full Text] [Related]
37. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS
Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252
[TBL] [Abstract][Full Text] [Related]
38. Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide.
Xu GW; Mymryk JS; Cairncross JG
Int J Cancer; 2005 Aug; 116(2):187-92. PubMed ID: 15800902
[TBL] [Abstract][Full Text] [Related]
39. Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure
Yamashiro K; Nakao K; Ohba S; Hirose Y
Anticancer Res; 2020 Mar; 40(3):1315-1323. PubMed ID: 32132028
[TBL] [Abstract][Full Text] [Related]
40. Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling.
Kani S; Nakayama E; Yoda A; Onishi N; Sougawa N; Hazaka Y; Umeda T; Takeda K; Ichijo H; Hamada Y; Minami Y
Genes Cells; 2007 Aug; 12(8):919-28. PubMed ID: 17663721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
